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Introduction: Patients of specialized nicotine dependence clinics are hypothesized to form a distinctsubpopulation of smokers due to the features associated with treatment seeking. The aim of the study
was to describe this subpopulation of smokers and compare it to smokers in general population.
Material and methods: A chart review of 796 outpatients attending a specialized nicotine dependence
clinic, located in Toronto, Ontario, Canada was performed. Client smoking patterns and sociode-
mographic characteristics were compared to smokers in the general population using two Ontario
surveys – the Ontario Tobacco Survey (n = 898) and the Centre for Addiction and Mental Health
Monitor (n = 457).
Results: Smokers who seek treatment tend to smoke more and be more heavily addicted. They were
older, had longer history of smoking and greater number of unsuccessful quit attempts, both assisted
and unassisted. They reported lower education and income, had less social support and were likely to
live with other smokers.
Conclusions: Smokers who seek treatment in specialized centers differ from the smokers in general
population on several important characteristics. These same characteristics are associated with lower
chances for successful smoking cessation and sustained abstinence and should be taken into consid-
eration during clinical assessment and treatment planning.
Keywords: Nicotine dependence, treatment seeking, smoking cessation, clinical populations
Introduction
Smoking is a major preventable cause of morbidity and
mortality worldwide (Lim et al., 2013). According to the
Canadian Tobacco Use Monitoring Survey Data there were
approximately 4.7 million smokers (16.7% of the popu-
lation) in Canada in 2010 (Reid, Hammond, Burkhal-
ter, & Ahmed, 2012). It was estimated that there were
37,000 tobacco-attributable deaths and CAD $17 billion
of tobacco-attributable costs in 2002 (Rehm et al., 2007).
The majority (60.2%) of smokers in Canada surveyed
in 2010 considered quitting smoking within the next 6
months and almost half of them (27.3% of the popula-
Corresponding author: Dr. Andriy V. Samokhvalov Centre for Addiction and Mental Health 33 Russell St, T519 M5V3R5, Toronto, Ontario Canada
E-mail: andriy.samokhvalov@camh.ca
tion) wanted to quit within the next month (Reid et al.,
2012). Unassisted cessation has been described as the
most successful method of quitting smoking, in part be-
cause of its reach (theoretically, universal) and because the
majority of former smokers have quit without formal
evidence-based psychosocial or pharmacological inter-
vention (Doran, Valenti, Robinson, Britt, & Mattick,
2006); (Hammond, McDonald, Fong, & Borland, 2004);
(Zhu, Melcer, J., Rosbrook, & Pierce, 2000).
While natural recovery is common in addictions
and in nicotine dependence in particular (Doran et al.,
2006; Klingemann, Sobell, & Sobell, 2009), recent data
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indicate that approximately 60% of smokers who are
currently trying to quit will use some form of cessa-
tion assistance (Reid et al., 2012). There are a number
of evidence-based approaches to smoking cessation such
as nicotine replacement therapy (Stead et al., 2012), phar-
macotherapy such as bupropion (Hughes, Stead, & Lan-
caster, 2007) or varenicline (Cahill, Stead, & Lancaster,
2012; Coe, Rollema, & O’Neill, 2009), and various forms
of behavioural interventions (Cummins, Bailey, Camp-
bell, Koon-Kirby, & Zhu, 2007; Stead & Lancaster, 2012).
Despite the natural recovery phenomenon and an abun-
dance of effective smoking cessation aids only 10% of
those who try to quit are able to maintain abstinence for
one year (Reid et al., 2012).
A proportion of smokers seek treatment in specialized
smoking cessation clinics. While this group is comprised
of individuals with mixed levels of dependence, smoking
patterns and other clinical characteristics, smokers seeking
help may differ from smokers in the general population
since those who have been successful at quitting unassisted
or without specialised assistance would not seek help at
a smoking cessation clinic. Thus, the subpopulation of
smokers seeking help in specialised cessation clinics may
include larger numbers of smokers who unsuccessfully
tried to quit before admission and are likely to possess
features associated with smoking cessation failure in the
past and, theoretically, in the future. There is a consensus
across the literature that treatment programmes should
be matched to their respective clientele in order to pro-
vide support adequate to their needs (Abrams et al., 1996;
Niaura & Abrams, 2002; Prochaska & Goldstein, 1991).
For example, heavier dependence and daily cigarette
consumption are associated with lower cessation rates
(Fagerström, Russ, Yu, Yunis, & Foulds, 2012) and thus
level of nicotine dependence should be taken into consid-
eration when providing treatment. Despite the potential
implications for clinical practice, few data are available on
the characteristics of smokers who seek professional help
at specialised smoking cessation clinics, and this group of
smokers is poorly described clinically. Therefore, the goal
of this study was to describe the subpopulation of smok-
ers who seek treatment in specialised smoking cessation
clinics in comparison to smokers in general population.
Material and methods
Subjects
In this study we compared three groups of smokers. The
first group consisted of smokers attending the Centre for
Addiction and Mental Health Nicotine Dependence Clinic
(NDC, n = 796) who were admitted between May 2008
and July 2010. The clinic is located in Toronto, Ontario,
Canada. The coverage of NDC includes mostly clients
from Toronto and the Greater Toronto Area with a popu-
lation of approximately 5.5 million people (40% of pop-
ulation of Ontario). The clinic is specialised in deliver-
ing smoking cessation services to clients of all levels of
complexity, including those with multiple comorbidities,
the prevalence of which is typically high, e.g. 26.9% of
the study sample had cardiovascular disorders, 30.2% had
respiratory disorders, 42.1% had some form of depres-
sive disorder, 37.8% have history of alcohol use disor-
der etc.). Services provided by the clinic are designed
to address the complex medical and social needs of the
clients and include psychosocial counselling, medical as-
sessments and interventions such as nicotine replacement
therapy (NRT), bupropion and varenicline. Almost all
clients are assessed by physicians and are either referred
to corresponding specialists at CAMH or other hospitals
or treated by addictions specialists or psychiatrists at the
clinic (e.g. mood and anxiety disorders, other addictions
etc.). The medical services are free of charge in Canada.
At the time of data collection patients with financial dif-
ficulties received subsidised NRT products via one of the
NDC’s research programmes. Medications are covered by
select drug plans (some private insurance plans and On-
tario Drug Benefit programme). All smokers seeking help
included in our study were residents of the Greater Toronto
Area.
Two groups of smokers in the general population were
obtained for comparison purposes from two large Ontario
surveys. The first group was obtained from participants in
the Ontario Tobacco Study (OTS) and second group was
obtained from participants in the Centre for Addiction
and Mental Health Monitor survey (CM). For the pur-
poses of our study, only OTS and CM respondents from
the Greater Toronto Area were included (OTS, n = 898
and CM, n = 457).
Data collection process
Data on NDC smokers were collected via a comprehensive
chart review. The timeframe of data collection was dictated
by availability of structured clinical records and availability
of a follow-up period of at least one year. The study was
approved by the CAMH Research Ethics Board. The chart
review was carried out by three trained research assistants.
The Ontario Tobacco Survey (OTS) is a population-
representative survey of 4,504 smokers and 3,001
non-smokers from Ontario. The cross-sectional survey
component of the OTS consists of a set of six random
digit dialling telephone surveys of Ontario adults (18 years
of age and over), stratified by region (Eastern, Greater
Toronto Area, South Western, and Northern based on
telephone area code) and smoking status (any smoking in
the past six months). Data collection for the first baseline
survey began in July 2005; collection of the final baseline
study was completed in June 2008. Overall, the OTS has
an adjusted response rate of 57% (ineligible and estimated
ineligible respondents were removed from the denomina-
tor); the smoker and non-smoker response rates were 61%
and 51%, respectively. Additional details on the study can
be found in (Diemert, Victor, Chaiton, & Bondy, 2010) or
online (www.otru.org). There were 898 smokers from the
Greater Toronto Area included in this comparison.
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Since data from the OTS predate the data from the
NDC sample (2005–08 vs. 2008–10), we also included data
for comparison purposes from the second general popula-
tion survey (CM) which included information from a time
period contemporaneous with the NDC sample. The CM
is an ongoing repeated cross-sectional telephone survey
of Ontario adults (18 and over), conducted for the Cen-
tre for Addiction and Mental Health by the Institute for
Social Research, York University.The survey is conducted
using list-assisted random-digit-dialling (RDD) methods
via Computer Assisted Telephone Interviewing (CATI).
Each annual cycle includes about 3,000 interviews annu-
ally. The design employs a stratified (by six regional area
codes) two-stage (telephone number; respondent) rolling
trimonthly probability selection procedure. Households
are selected at random. Within selected households, one
respondent aged 18 or older who could complete the in-
terview in English is selected at random. To obtain equal
precision of estimates within different areas of Ontario,
the sample is equally allocated among six regional strata
based on area code. For purposes of the current study, a
merged dataset based on the aggregation of three cycles
(2008 to 2010) of the CAMH Monitor was used.The re-
sponse rate for the three cycles varied from 51% to 53%.
The data were weighted to adjust for selection probabili-
ties, regional representation and a final post-stratification
adjustment to restore the age by gender distribution based
on the most recently available census data. The weighted
sample is considered representative for the Ontario
general adult population. Further details about the sur-
vey can be found in (lalomiteanu & Adlaf, 2012).
Measures
The data extracted during the NDC chart review included
socio-demographic characteristics (age, gender, education
and income level, presence and smoking status of partner)
and smoking variables (including number of cigarettes
smoked per day (CPD), age when the first cigarette was
smoked, age when subjects became regular smokers, num-
ber of years of regular smoking, number of quit attempts,
previously used smoking cessation aids). Severity of smok-
ing was assessed with the use of the Fagerström Test for
Nicotine Dependence (FTND, (Heatherton, Kozlowski,
Frecker, & Fagerström, 1991) and the Heaviness of Smok-
ing Index (HSI, (Heatherton, Kozlowski, Frecker, Rickert,
& Robinson, 1989). Motivation to quit smoking was as-
sessed using readiness to quit, importance of current quit
attempt and confidence in quitting success scales (Bert-
holet, Gaume, Faouzi, Gmel, & Daeppen, 2012; Miller &
Rollnick, 2002).
The NDC data were compared to homologous vari-
ables obtained from the Greater Toronto Area respondents
of the OTS and CM. Further details on measures included
in OTS and CM are available elsewhere (Diemert et al.,
2010; Ialomiteanu & Adlaf, 2012).
Data analysis
We used χ2 tests to compare non-parametric data and
independent-measures t-tests to compare parametric data
between the three samples.
Results
Sociodemographic parameters
Gender distribution was similar in the three groups of
smokers. All three groups tended to have more males than
females (53.6% vs. 46.4% in NDC, 56.0% vs. 44.0% in
OTS and 57.2% vs. 42.9% in CM smokers, see Table 1),
although the preponderance of males was significantly less
in the NDC compared to the CM samples. NDC smokers
were significantly older than smokers in OTS and CM, by
7 and 4 years, respectively. Smokers older than 35 years
were most common in the NDC sample, whereas the pop-
ulation survey samples had more younger (18–34 years)
respondents.
NDC smokers had the highest proportion of subjects
with low education level – 57.2% vs. 40.7% in OTS and
44.2% in CM. More than a half (58.2%) of NDC smokers
were receiving disability support (no smokers reported re-
ceiving disability in the OTS) and almost three quarters of
them had low income compared to 16.1% of CM smokers
with low income. NDC smokers were less likely to report
a spouse or common-law partner – 30.4% of them had a
spouse or common-law partner compared to 54.1% and
58.8% in OTS and CM, respectively. Interestingly, 39.2%
of partners of NDC smokers were smokers themselves.
Smoking parameters
The average Fagerström Test for Nicotine Dependence
score in the NDC sample was 6.1, which corresponds to se-
vere dependence. The Heaviness of Smoking Index (HSI)
is one of the most reliable indicators of severity of nicotine
dependence and was available for all three samples. The
average HSI score was significantly higher in NDC smok-
ers (3.4) compared to smokers in the OTS (1.9) and CM
(2.3) samples (see Table 2). The distributions of its two
items (time to first cigarette after waking up in the morn-
ing and number of cigarettes smoked per day) differed
over the samples. Almost half (47.6%) of NDC smokers
would have their first cigarette within the first 5 minutes),
while only 12.0% and 19.9% of OTS and CM smokers re-
spectively would do so. Approximately half of the smokers
in both surveys would have their first cigarette more than
30 minutes after waking up.
There was also a significant difference in average
cigarette consumption, with OTS smokers reporting on
average 13.3 CPD and NDC smokers reported a pre-
treatment consumption of 20.3 CPD. NDC smokers re-
ported having had their first cigarette at around 16 years of
age (15.8). The age of becoming a regular smoker did not
differ significantly between the NDC sample (17.4 years)
and the OTS sample (17.7 years). However, the NDC
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Table 1
Comparison of sociodemographic characteristics of smokers seeking help in Nicotine Dependence Clinic to smokers in Ontario Tobacco Survey and smokers in CAMH Monitor survey.
Smokers in Ontario Tobacco Survey (n = 898) Smokers in CAMH Monitorsurvey (n = 457)
Smokers in Nicotine Dependence Clinic (n = 796) Comparison to smokers seeking help Comparison to smokers seeking help
M /% 95% CI M /% 95% CI X2 / t df p-value M /% 95% CI X2 / t df p-value
Gender
Female 46.4% 42.9-49.8% 44.0% 40.4-47.7% 1.8 1 0.179 42.9% 37.7-48.2% 4.0 1 0.046
Male 53.6% 50.2-57.1% 56.0% 52.3-59.6% 57.2% 51.8-62.3%
Age 46.5 45.7-47.4 39.5 38.4-40.6 9.7 1662 <0.001 42.5 40.8-44.1 5.6 1251 <0.001
Age distribution
18-34 18.1% 15.4-20.8% 40.3% 36.6-44.1% 197.1 2 <0.001 32.9% 27.5-38.7% 78.8 2 <0.001
35-54 55.4% 51.9-58.9% 45.4% 41.8-49.2% 45.1% 39.8-50.5%
55 and older 26.5% 23.4-29.6% 14.3% 12.0-17.0% 22.1% 18.4-26.2%
Education level
Low 57.2% 53.7-60.7% 40.7% 37.0-44.5% 84.4 1 <0.001 44.2% 39.0-49.7% 51.1 1 <0.001
Medium-high 42.8% 39.3-46.3% 59.3% 55.5-63.0% 55.8% 50.3-61.1%
Disability support
Yes 58.2% 54.8-61.7% * * - - - - - - - -
No 41.8% 38.3-45.2% * *
Income distribution
Low (less than $40,000) 73.6% 70.5-76.7% - - - - - 16.1% 12.5-20.5% 1800.4 2 <0.001
Medium ($40,000-125,000) 24.4% 21.4-27.4% - - 39.2% 34.2-44.4%
High (more than $125,000) 2.0% 1.0-3.0% - - 20.1% 16.0-25.0%
Partner (Spouse or common-law)
Yes 30.4% 27.2-33.6% 54.1% 50.3-57.8% 178.5 1 <0.001 58.5% 53.1-63.8% 258.1 1 <0.001
Non-smoker 30.0% 24.2-35.8%
Smoker 39.2% 33.0-45.4%
Smoking status unknown 30.8% 25.0-36.7%
No 69.6% 66.4-72.8% 45.9% 42.2-49.7% 41.5% 36.2-46.9%
Smoking in household 40.5% 36.9-44.0% 34.5% 31.1-38.0% 11.7 1 0.001 40.6% 32.9-48.7% 0.0 1 0.967
59.5% 56.0-63.1% 65.5% 61.8-68.7% 59.4% 51.3-67.1%
* The data on disability in Ontario Tobacco Survey were not reportable
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Table 2
Comparison of smoking variables in smokers seeking help in Nicotine Dependence Clinic to smokers in Ontario Tobacco Survey and smokers in CAMH Monitor survey.
Smokers in Ontario Tobacco Survey(n = 898) Smokers in CAMH Monitor survey (n = 457)
Smokers in Nicotine Dependence Clinic (n = 796) Comparison to smokers seeking help Comparison to smokers seeking help
M /% 95% CI M /% 95% CI X2 / t df p-value M /% 95% CI X2 / t df p-value
Severity of nicotine dependence
Fagerström test for nicotine dependence 6.1 5.9-6.2 - - - - - - - - - -
Heaviness of smoking index 3.4 3.3-3.5 1.9 1.8-2.0 17.1 1634 <0.001 2.3 2.0-2.5 13.2 1132 <0.001
Time to first cigarette in the morning
Less than 5 min 47.6% 44.1-51.2% 12.0% 9.7-14.6% 1052.3 2 <0.001 19.9% 15.8-24.8% 440.4 2 <0.001
Between 6 and 30 min 28.1% 25.0-31.3% 33.3% 29.6-37.1% 33.7% 28.2-39.6%
More than 30 min 20.7% 17.9-23.6% 54.8% 50.8-58.7% 46.4% 40.4-52.5%
Smoking history
Age of first cigarette 15.8 15.5-16.2 - - - - - - - - - -
Age became regular smoker 17.4 17.0-17.8 17.7 17.3-18.1 0.9 1517 0.359 - - - - -
Transition to regular smoking, years 1.5 1.3-1.7 - - - - - - - - - -
Regular smoking history, years 28.9 28.0-29.8 23.1 21.9-24.3 7.5 1517 <0.001 - - - - -
Daily cigarette consumption 20.3 19.4-21.2 13.3 12.5-14.1 11.5 1553 <0.001 11.7 10.5-13.0 8.6 1246 <0.001
Attitude to quitting
Importance (0-10) 9.0 8.9-9.1 - - - - - - - - - -
Confidence (0-10) 7.0 6.9-7.2 - - - - - - - - - -
Readiness (0-10) 8.4 8.1-8.6 - - - - - - - - - -
Confidence in quitting success
Not confident at all 4.4% 2.9-5.8% 11.3% 9.2-13.4% 149.6 3 <0.001 - - - - -
Not very confident 22.5% 19.5-25.4% 24.3% 21.5-27.2%
Fairly confident 24.1% 21.1-27.1% 35.6% 32.4-38.8%
Very confident 45.9% 42.3-49.4% 28.7% 25.7-31.7%
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smokers had a longer history of daily smoking compared
to OTS smokers (28.9 vs. 23.7 years).
Data on motivation to quit were available only for
NDC smokers. Average importance level was very close to
the maximum of the scale, at 9.0. Levels of confidence and
readiness were also very high, at 7.0 and 8.4, respectively.
The only parameter that could be compared was confi-
dence in quitting success which was also available in the
OTS dataset. Interestingly, confidence to quit appeared
higher in clinic attendees. There were almost no people
who were not confident at all in NDC sample (4.4% com-
pared to 11.3% in OTS), while a much higher proportion
of NDC smokers compared to OTS smokers were very
confident in the success of their quitting attempt (45.9%
vs. 38.7%).
Smoking cessation history
NDC smokers on average reported having made twice
as many quit attempts, in their lifetime, compared to
OTS smokers (3.2 vs. 1.6 attempts). Average time since
the most recent quit attempt in NDC sample exceeded
four and a half years (55.0 months) and average dura-
tion of the longest quit attempt was more than one year
(16.4 months). The majority of NDC clients also had an
extensive history of smoking cessation aids use. The most
commonly used smoking cessation aid was nicotine re-
placement therapy. About twice as many NDC smokers
used various forms of nicotine replacement therapy in
the past compared to OTS smokers (77.5% vs. 42.6%).
Similarly, NDC smokers were more likely to report a pre-
vious history of bupropion use (29.4% of NDC smokers
had used it before admission compared to 16.4% of OTS
smokers) and varenicline use (8.9% vs. 2.3%).
Discussion
The effectiveness of Interventions to support cessation are
well-supported by clinical trials (Cahill et al., 2012; Hughes
et al., 2007; Stead & Lancaster, 2012; Stead et al., 2012).
However, proper cessation programme delivery needs to
be guided by considerations such as matching the form
and intention of treatment to the characteristics of the
sample, and ensuring that those clients who have the most
difficulty quitting obtain support that is consistent with
their needs (Abrams et al., 1996; Niaura & Abrams, 2002;
Prochaska & Goldstein, 1991). This study is unique in
being able to describe a sample of clients of a publicly-
funded smoking cessation programme and examine the
differences between this sample of smokers seeking help
and population based samples of smokers not seeking
help.
The characteristic features of the smokers who sought help at a
specialised cessation clinic
As expected, smokers who sought help at the NDC
were significantly different from smokers in general
population – while becoming regular smokers at approx-
imately the same age they tended to be older at the time
JOURNAL OF SMOKING CESSATION 81
https://doi.org/10.1017/jsc.2013.23
Downloaded from https://www.cambridge.org/core. SLUB Dresden, on 03 Feb 2020 at 09:27:04, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
Andriy V. Samokhvalov et al.
of admission and had a longer history of regular smoking.
They smoked twice as many cigarettes on a daily basis,
were more heavily dependent than smokers in the general
population and tended to have an extensive history of both
smoking cessation attempts and previous use of various
smoking cessation aids. Almost all the clinic sampled had
previously tried to use NRT at some point and they were
much more likely to have previously tried smoking cessa-
tion medications than smokers in the general population.
This supports our hypothesis that smokers who seek the
most specialised help have unsuccessfully tried to quit in
the past, both on their own and with assistance.
Smokers who sought treatment at the specialised nico-
tine dependence clinic also had lower income and educa-
tional levels attainment than smokers in the comparison
samples. This is consistent with the hypothesis that the
poorest socio-economic groups have lower odds of quit-
ting and suffer more from the consequences of tobacco use
(Bobak, Jha, Nguyen, & Jarvis, 2000). More than half of
smokers seeking help received disability support and were
less likely to have a life partner and, thus, may lack the
additional motivation and support for their quitting at-
tempt that a partner can provide. However, over one third
of the partners of the clinic attendees were also smokers.
This is higher than the prevalence of smoking in Canada,
similar to previously published data on smoking patterns
in partners of low socioeconomic status smokers and is
also associated with lower cessation rates (Okechukwu,
Nguyen, & Hickman, 2010).
Implications for clinical practice
The heavier smoking and higher dependence levels ob-
served in this sample of smokers seeking help in specialised
treatment centres are associated with significantly lower
cessation rates and higher chances of relapse (Fagerström
et al., 2012). Also, though there was no direct comparison
made to smokers in the general population in terms of
prevalence of somatic and mental comorbidities, clients
seeking help in a smoking cessation clinic demonstrate
a high prevalence of cardiovascular and respiratory dis-
orders, mood and anxiety disorders and other addictive
behaviours, which can be interpreted in several ways. On
the one hand, smoking is associated with multiple somatic
comorbidities and their high prevalence might be an indi-
cator of severity of dependence and heavy smoking prior
to attendance. Persistent health problems are also likely to
affect smokers’ motivation to quit (McCaul et al., 2006).
On the other hand, mental comorbidities, such as bipo-
lar affective disorder or schizophrenia are associated with
very heavy smoking and poor treatment outcomes (Selby,
Voci, Zawertailo, George, & Brands, 2010); (Williams &
Ziedonis, 2004). Thus, smokers’ health state and amnaesic
data should be taken into consideration when developing
a treatment plan.
In addition to clinical characteristics associated with
worse outcomes, socioeconomic features of the smokers
who attend specialised treatment such as low income and
education level might pose additional barriers to treat-
ment due to cost of medications or nicotine replacement
therapy products (if they are not covered by health insur-
ance), transportation costs etc. These data support im-
plementation of subsidised or fully covered treatment
programmes for smokers with low income. Such pro-
grammes are shown to be effective for these populations
(Woolacott et al., 2002). At the same time we must ac-
knowledge the fact that the NDC provides subsidised
treatment to those who require it. While subsidisation
of treatment might have increased, the incentives for peo-
ple of low socio-economic to seek treatment have not;
in general in the Canadian health care system access to
care is better among those of higher socio-economic sta-
tus (Bulter-Jones, 2008). Also, higher socio-economic sta-
tus individuals may be able to draw on other financial
and social resources to quit smoking without specialised
medical help. The prevalence of smoking is known to be
higher in lower socio-economic strata (Bobak et al., 2000),
and combined with a high incidence of smoking partners
or other smokers in household, lower SES smokers may
have higher relapse risk due to additional exposure to
smoking cues, peer pressure and readily available tobacco
products.
Study limitations
The study has two major limitations need to be consid-
ered when interpreting the results. First, the data collection
process differed between the NDC sample and the popu-
lation surveys. We must note that NDC clinicians, how-
ever, use standardised data collection procedures which
incorporate many of the questions asked in the surveys.
Also, most of the questions involved straightforward de-
mographic information (e.g., age, gender) for which we
would not expect significant bias due to the difference
in study designs. Second, as noted, there is a difference
in the time of data collection between the NDC sam-
ple (2008–2010) and the OTS sample (2005–2008) and
so there might be changes in some variables over time.
However, we believe that the relatively small temporal dif-
ference of three years is not likely to result in substantial
differences between the NDC and OTS samples. Also, in-
clusion of the CM sample collected at the same time as the
NDC sample, and the observation of substantial similarity
between the CM and OTS samples further suggested that
any temporally-related differences between the OTS and
NDC samples are likely to be minimal and do not reach
statistical significance.
Conclusions
Smokers who seek treatment in specialised smoking ces-
sation clinics differ in important ways from smokers in
the general population. They are more heavily depen-
dent, smoke more cigarettes on a daily basis, are older and
have a longer history of smoking and greater number of
unsuccessful smoking cessation attempts. They have less
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education and lower income, may have less social sup-
port for quitting, and are likely to live with other smokers.
These characteristics are associated with lower chances
for successful smoking cessation and sustained abstinence
and should be taken into consideration during clinical
assessment and treatment planning.
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